Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Clinical trial NCT04693637 · COMPLETED

Trial details

NCT number: NCT04693637
Sponsor: AlloVir
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Adenovirus Infection BK Virus Infection Cytomegalovirus Infections Epstein-Barr Virus Infections Human Herpes Virus-6 Infection JC Virus Infection

Start date: 2021-01-15
Primary completion: 2023-01-19
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.